Aggressive sino-nasal non-Hodgkin's lymphoma diagnosed in Nottinghamshire, UK, between 1987 and 1996

被引:0
|
作者
Quraishi, MS
Bessell, EM
Clark, DM
Jones, NS
Bradley, PJ
机构
[1] City Hosp Nottingham, Dept Clin Oncol, Nottingham NG5 1PB, England
[2] Univ Nottingham Hosp, Nottingham NG7 2UH, England
关键词
chemotherapy; lymphoma; nasal cavity; paranasal sinuses; radiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the 10-year period 1987 to 1996, 24 patients were diagnosed with aggressive non-Hodgkin's lymphoma of the nasal cavities or paranasal sinuses. The disease occurred in a relatively elderly population of median age 72 years (range 42 to 96) with a male predominance (male 15; female nine). The histology on review was mostly of the large B-cell subtype (21 patients); peripheral T-cell subtype (one), anaplastic large cell of T-cell type (one) and T/natural killer cell nasal lymphoma (one). The disease was localized in 20 patients (Stage I(E)A). The overall survival at 5 years was 40% (95% confidence interval (CI) 19-61); at 10 years it was 33% (95% CI 12-54). The cause-specific survival (excluding deaths from causes other than lymphoma) at 5 years and 10 years was 62% (95% CI 39-86).
引用
收藏
页码:269 / 272
页数:4
相关论文
共 50 条
  • [1] Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma
    Mahadevan, Daruka
    Fisher, Richard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (14) : 1876 - 1884
  • [2] Non-Hodgkin's lymphoma of the knee diagnosed by arthroscopy
    Mileti, Joseph
    Mileti, Linda
    Kaeding, Christopher
    ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY, 2007, 23 (04): : 447.e1 - 447.e4
  • [3] Localized, aggressive non-Hodgkin's lymphoma of the nasal cavity: A survey by the Japan Lymphoma Radiation Therapy Group
    Shikama, N
    Ikeda, H
    Nakamura, S
    Oguchi, M
    Isobe, K
    Hirota, S
    Hasegawa, M
    Nakamura, K
    Sasai, K
    Hayabuchi, N
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (05): : 1228 - 1233
  • [4] Current Guidelines for the Management of Aggressive Non-Hodgkin’s Lymphoma
    Maurizio Martelli
    Vitaliana De Sanctis
    Giuseppe Avvisati
    Franco Mandelli
    Drugs, 1997, 53 : 957 - 972
  • [5] Therapy for stage I aggressive non-Hodgkin's lymphoma
    Kluin-Nelemans, HC
    CROATIAN MEDICAL JOURNAL, 2002, 43 (05) : 546 - 549
  • [6] Early death in patients diagnosed with non-Hodgkin's lymphoma
    Bairey, Osnat
    Bar-Natan, Michal
    Shpilberg, Ofer
    ANNALS OF HEMATOLOGY, 2013, 92 (03) : 345 - 350
  • [7] Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma
    Blaes, Anne H.
    Ma, Linan
    Zhang, Yan
    Peterson, Bruce A.
    LEUKEMIA & LYMPHOMA, 2011, 52 (11) : 2105 - 2110
  • [8] Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma
    Prichard, Mark
    Harris, Thomas
    Williams, Michael E.
    Densmore, John J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (06) : 983 - 995
  • [9] Aggressive Non-Hodgkin's lymphoma with massive involvement of the right ventricle
    Tanaka, T
    Sato, T
    Akifuji, Y
    Sakamoto, M
    Shio, H
    Ueki, J
    Taniguchi, I
    Nakamoto, S
    INTERNAL MEDICINE, 1996, 35 (10) : 826 - 830
  • [10] Cost analysis of CHOP (-like) chemotherapy regimens for patients with newly diagnosed aggressive non-Hodgkin's lymphoma
    van Agthoven, M
    Faber, LM
    Uyl-de Groot, CA
    Sonneveld, P
    Verdonck, LF
    Willemze, R
    Kluin-Nelemans, JC
    Löwenberg, B
    Huijgens, PC
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2002, 69 (04) : 213 - 220